MRSA Detection Oligonucleotides Coamplification Threshold
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current molecular approaches for detecting methicillin-resistant Staphylococcus aureus (MRSA) are plagued by false-positive and false-negative results, particularly in complex samples like nasal swabs, due to sequence divergence and coinfection with other methicillin-resistant bacteria, leading to inaccurate diagnoses.
Innovation Solution
A method involving oligonucleotides with specific target-complementary base sequences and detectably labeled hybridization probes is used to coamplify S. aureus-specific and methicillin resistance markers in a nucleic acid amplification reaction, with a threshold criterion to differentiate MRSA from other bacteria, reducing false-positive determinations by calculating a numerical value based on amplification kinetics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If junction-based amplification procedures are used to detect MRSA, then detection speed is improved, but false-positive results increase due to sequence divergence and coinfection with other methicillin-resistant bacteria
Solution Approach 1:
The detection system is divided into multiple independent components: a methicillin resistance marker detection system and a staphylococcal species marker detection system. These segmented systems work together to provide both rapid detection and accurate differentiation, resolving the contradiction between speed and precision by separating the detection functions into distinct modular units that can be independently optimized.
2Adaptability or versatility
If multiple primers and molecular beacon probes are used to detect SCCmec, then detection coverage is improved, but assay complexity increases
Solution Approach 1:
The invention employs universal primer sets that can amplify methicillin resistance markers across different staphylococcal species, and species-specific markers that universally identify S. aureus versus coagulase-negative staphylococci. This multi-functional approach allows a single assay system to detect and differentiate multiple pathogens simultaneously, improving detection coverage without proportionally increasing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces false-positive MRSA determinations by accurately distinguishing MRSA from mixtures of methicillin-sensitive S. aureus and methicillin-resistant coagulase-negative staphylococci, enhancing diagnostic accuracy in clinical samples.
Implementation Method 1
A first oligonucleotide that has a target-complementary base sequence consisting of SEQ ID NO:1, and a second oligonucleotide up to 60 bases in length that has a target-complementary base sequence consisting of SEQ ID NO:4
Implementation Method 2
oligonucleotides with specific target-complementary base sequences
Implementation Method 3
only one of the first and second oligonucleotides has a 3′ end that can be extended by a template-dependent DNA polymerase
Implementation Method 4
The composition also includes a detectably labeled hybridization probe
Data Source
AI summary
Method of detecting methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in a nucleic acid coamplification assay. The invention advantageously reduces the incidence of false-positive MRSA determinations in real-time assays by requiring satisfaction of a threshold criterion that excludes certain co-infections from the MRSA determination. The invention further provides for determination of MSSA, even when the MSSA is present in combination with methicillin-resistant coagulase-negative (MR-CoNS) bacteria at high or low levels.